Global Cancer Immunotherapy Market By Technology (Monoclonal Antibodies, Cytokines & Immunomodulators), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer), End User (Hospitals, Clinics)

Published Date : 20-11-2018

Pages: 229

Formats: PDF

COVID-19 Impact on the Cancer Immunotherapy Market

Market Overview

The Global Cancer Immunotherapy Market size is expected to reach $128.3 billion by 2024, rising at a market growth of 14.3% CAGR during the forecast period.
Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors, cytokines, and others. Growing patient population that is suffering from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric population and governmental contribution to healthcare expenditure are some other factors that add to the market growth.

Global Cancer Immunotherapy Market Size

Click Here For Free Insights

Based on technology, the Cancer Immunotherapy Market Size is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology. Based on application, the market is segmented into Lung cancer, Breast cancer, Colorectal, Prostate cancer, Head & Neck cancer and other application. Based on end user the market is segmented into Hospitals, Clinics and other end user.. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

Global Cancer Immunotherapy Market Share

The Cancer Immunotherapy Market Analysis report covers the analysis of key stake holders of the market. Key companies profiled in the report include AstraZeneca, Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Bayer Ag, Immunomedics Inc., Novartis AG, F. Hoffmann-La Roche LtdA

Scope of the Study

Market Segmentation:

By Technology

Monoclonal Antibodies,
Cytokines & Immunomodulators
Other technology

By Application

By End User

Hospitals
Clinics
Other End User

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Table of contents

Chapter 1.   Market Scope & Methodology
1.1   Market Definition
1.2   Objectives
1.3   Market Scope
1.4   Segmentation
1.4.1   Global Cancer Immunotherapy Market, by Technology
1.4.2   Global Cancer Immunotherapy Market, by Application
1.4.3   Global Cancer Immunotherapy Market, by End User
1.4.4   Global Cancer Immunotherapy Market, by Geography
1.5   Methodology for the research
Chapter 2.   Market Overview
2.1   Introduction
2.2   Key Factors Impacting the Market
2.2.1   Market Drivers
2.2.2   Market Restraints
Chapter 3.   Global Cancer Immunotherapy Market by Technology
3.1.1   Global Monoclonal Antibodies Cancer Immunotherapy Market by Region
3.1.2   Global Cytokines & Immunomodulators Cancer Immunotherapy Market by Region
3.1.3   Global Other Technology Cancer Immunotherapy Market by Region
Chapter 4.   Global Cancer Immunotherapy Market by Application
4.1.1   Global Cancer Immunotherapy Lung Cancer Market by Region
4.1.2   Global Cancer Immunotherapy Breast Cancer Market by Region
4.1.3   Global Cancer Immunotherapy Colorectal Cancer Market by Region
4.1.4   Global Cancer Immunotherapy Melanoma Market by Region
4.1.5   Global Cancer Immunotherapy Prostate Cancer Market by Region
4.1.6   Global Cancer Immunotherapy Head & Neck Cancer Market by Region
4.1.7   Global Other Application Cancer Immunotherapy Market by Region
Chapter 5.   Global Cancer Immunotherapy Market by End User
5.1.1   Global Hospitals Cancer Immunotherapy Market by Region
5.1.2   Global Clinics Cancer Immunotherapy Market by Region
5.1.3   Global Other End User Cancer Immunotherapy Market by Region
Chapter 6.   Global Cancer Immunotherapy Market by Region
6.1   North America Cancer Immunotherapy Market
6.1.1   North America Cancer Immunotherapy Market by Technology
6.1.1.1   North America Monoclonal Antibodies Cancer Immunotherapy Market by Country
6.1.1.2   North America Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
6.1.1.3   North America Other Technology Cancer Immunotherapy Market by Country
6.1.2   North America Cancer Immunotherapy Market by Application
6.1.2.1   North America Cancer Immunotherapy Lung Cancer Market by Country
6.1.2.2   North America Cancer Immunotherapy Breast Cancer Market by Country
6.1.2.3   North America Cancer Immunotherapy Colorectal Cancer Market by Country
6.1.2.4   North America Cancer Immunotherapy Melanoma Market by Country
6.1.2.5   North America Cancer Immunotherapy Prostate Cancer Market by Country
6.1.2.6   North America Cancer Immunotherapy Head & Neck Cancer Market by Country
6.1.2.7   North America Other Application Cancer Immunotherapy Market by Country
6.1.3   North America Cancer Immunotherapy Market by End User
6.1.3.1   North America Hospitals Cancer Immunotherapy Market by Country
6.1.3.2   North America Clinics Cancer Immunotherapy Market by Country
6.1.3.3   North America Other End User Cancer Immunotherapy Market by Country
6.1.4   North America Cancer Immunotherapy Market by Country
6.1.4.1   US Cancer Immunotherapy Market
6.1.4.1.1   US Cancer Immunotherapy Market by Technology
6.1.4.1.2   US Cancer Immunotherapy Market by Application
6.1.4.1.3   US Cancer Immunotherapy Market by End User
6.1.4.2   Canada Cancer Immunotherapy Market
6.1.4.2.1   Canada Cancer Immunotherapy Market by Technology
6.1.4.2.2   Canada Cancer Immunotherapy Market by Application
6.1.4.2.3   Canada Cancer Immunotherapy Market by End User
6.1.4.3   Mexico Cancer Immunotherapy Market
6.1.4.3.1   Mexico Cancer Immunotherapy Market by Technology
6.1.4.3.2   Mexico Cancer Immunotherapy Market by Application
6.1.4.3.3   Mexico Cancer Immunotherapy Market by End User
6.1.4.4   Rest of North America Cancer Immunotherapy Market
6.1.4.4.1   Rest of North America Cancer Immunotherapy Market by Technology
6.1.4.4.2   Rest of North America Cancer Immunotherapy Market by Application
6.1.4.4.3   Rest of North America Cancer Immunotherapy Market by End User
6.2   Europe Cancer Immunotherapy Market
6.2.1   Europe Cancer Immunotherapy Market by Technology
6.2.1.1   Europe Monoclonal Antibodies Cancer Immunotherapy Market by Country
6.2.1.2   Europe Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
6.2.1.3   Europe Other Technology Cancer Immunotherapy Market by Country
6.2.2   Europe Cancer Immunotherapy Market by Application
6.2.2.1   Europe Cancer Immunotherapy Lung Cancer Market by Country
6.2.2.2   Europe Cancer Immunotherapy Breast Cancer Market by Country
6.2.2.3   Europe Cancer Immunotherapy Colorectal Cancer Market by Country
6.2.2.4   Europe Cancer Immunotherapy Melanoma Market by Country
6.2.2.5   Europe Cancer Immunotherapy Prostate Cancer Market by Country
6.2.2.6   Europe Cancer Immunotherapy Head & Neck Cancer Market by Country
6.2.2.7   Europe Other Application Cancer Immunotherapy Market by Country
6.2.3   Europe Cancer Immunotherapy Market by End User
6.2.3.1   Europe Hospitals Cancer Immunotherapy Market by Country
6.2.3.2   Europe Clinics Cancer Immunotherapy Market by Country
6.2.3.3   Europe Other End User Cancer Immunotherapy Market by Country
6.2.4   Europe Cancer Immunotherapy Market by Country
6.2.4.1   Germany Cancer Immunotherapy Market
6.2.4.1.1   Germany Cancer Immunotherapy Market by Technology
6.2.4.1.2   Germany Cancer Immunotherapy Market by Application
6.2.4.1.3   Germany Cancer Immunotherapy Market by End User
6.2.4.2   UK Cancer Immunotherapy Market
6.2.4.2.1   UK Cancer Immunotherapy Market by Technology
6.2.4.2.2   UK Cancer Immunotherapy Market by Application
6.2.4.2.3   UK Cancer Immunotherapy Market by End User
6.2.4.3   France Cancer Immunotherapy Market
6.2.4.3.1   France Cancer Immunotherapy Market by Technology
6.2.4.3.2   France Cancer Immunotherapy Market by Application
6.2.4.3.3   France Cancer Immunotherapy Market by End User
6.2.4.4   Russia Cancer Immunotherapy Market
6.2.4.4.1   Russia Cancer Immunotherapy Market by Technology
6.2.4.4.2   Russia Cancer Immunotherapy Market by Application
6.2.4.4.3   Russia Cancer Immunotherapy Market by End User
6.2.4.5   Spain Cancer Immunotherapy Market
6.2.4.5.1   Spain Cancer Immunotherapy Market by Technology
6.2.4.5.2   Spain Cancer Immunotherapy Market by Application
6.2.4.5.3   Spain Cancer Immunotherapy Market by End User
6.2.4.6   Italy Cancer Immunotherapy Market
6.2.4.6.1   Italy Cancer Immunotherapy Market by Technology
6.2.4.6.2   Italy Cancer Immunotherapy Market by Application
6.2.4.6.3   Italy Cancer Immunotherapy Market by End User
6.2.4.7   Rest of Europe Cancer Immunotherapy Market
6.2.4.7.1   Rest of Europe Cancer Immunotherapy Market by Technology
6.2.4.7.2   Rest of Europe Cancer Immunotherapy Market by Application
6.2.4.7.3   Rest of Europe Cancer Immunotherapy Market by End User
6.3   Asia Pacific Cancer Immunotherapy Market
6.3.1   Asia Pacific Cancer Immunotherapy Market by Technology
6.3.1.1   Asia Pacific Monoclonal Antibodies Cancer Immunotherapy Market by Country
6.3.1.2   Asia Pacific Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
6.3.1.3   Asia Pacific Other Technology Cancer Immunotherapy Market by Country
6.3.2   Asia Pacific Cancer Immunotherapy Market by Application
6.3.2.1   Asia Pacific Cancer Immunotherapy Lung Cancer Market by Country
6.3.2.2   Asia Pacific Cancer Immunotherapy Breast Cancer Market by Country
6.3.2.3   Asia Pacific Cancer Immunotherapy Colorectal Cancer Market by Country
6.3.2.4   Asia Pacific Cancer Immunotherapy Melanoma Market by Country
6.3.2.5   Asia Pacific Cancer Immunotherapy Prostate Cancer Market by Country
6.3.2.6   Asia Pacific Cancer Immunotherapy Head & Neck Cancer Market by Country
6.3.2.7   Asia Pacific Other Application Cancer Immunotherapy Market by Country
6.3.3   Asia Pacific Cancer Immunotherapy Market by End User
6.3.3.1   Asia Pacific Hospitals Cancer Immunotherapy Market by Country
6.3.3.2   Asia Pacific Clinics Cancer Immunotherapy Market by Country
6.3.3.3   Asia Pacific Other End User Cancer Immunotherapy Market by Country
6.3.4   Asia Pacific Cancer Immunotherapy Market by Country
6.3.4.1   China Cancer Immunotherapy Market
6.3.4.1.1   China Cancer Immunotherapy Market by Technology
6.3.4.1.2   China Cancer Immunotherapy Market by Application
6.3.4.1.3   China Cancer Immunotherapy Market by End User
6.3.4.2   Japan Cancer Immunotherapy Market
6.3.4.2.1   Japan Cancer Immunotherapy Market by Technology
6.3.4.2.2   Japan Cancer Immunotherapy Market by Application
6.3.4.2.3   Japan Cancer Immunotherapy Market by End User
6.3.4.3   India Cancer Immunotherapy Market
6.3.4.3.1   India Cancer Immunotherapy Market by Technology
6.3.4.3.2   India Cancer Immunotherapy Market by Application
6.3.4.3.3   India Cancer Immunotherapy Market by End User
6.3.4.4   South Korea Cancer Immunotherapy Market
6.3.4.4.1   South Korea Cancer Immunotherapy Market by Technology
6.3.4.4.2   South Korea Cancer Immunotherapy Market by Application
6.3.4.4.3   South Korea Cancer Immunotherapy Market by End User
6.3.4.5   Singapore Cancer Immunotherapy Market
6.3.4.5.1   Singapore Cancer Immunotherapy Market by Technology
6.3.4.5.2   Singapore Cancer Immunotherapy Market by Application
6.3.4.5.3   Singapore Cancer Immunotherapy Market by End User
6.3.4.6   Malaysia Cancer Immunotherapy Market
6.3.4.6.1   Malaysia Cancer Immunotherapy Market by Technology
6.3.4.6.2   Malaysia Cancer Immunotherapy Market by Application
6.3.4.6.3   Malaysia Cancer Immunotherapy Market by End User
6.3.4.7   Rest of Asia Pacific Cancer Immunotherapy Market
6.3.4.7.1   Rest of Asia Pacific Cancer Immunotherapy Market by Technology
6.3.4.7.2   Rest of Asia Pacific Cancer Immunotherapy Market by Application
6.3.4.7.3   Rest of Asia Pacific Cancer Immunotherapy Market by End User
6.4   LAMEA Cancer Immunotherapy Market
6.4.1   LAMEA Cancer Immunotherapy Market by Technology
6.4.1.1   LAMEA Monoclonal Antibodies Cancer Immunotherapy Market by Country
6.4.1.2   LAMEA Cytokines & Immunomodulators Cancer Immunotherapy Market by Country
6.4.1.3   LAMEA Other Technology Cancer Immunotherapy Market by Country
6.4.2   LAMEA Cancer Immunotherapy Market by Application
6.4.2.1   LAMEA Cancer Immunotherapy Lung Cancer Market by Country
6.4.2.2   LAMEA Cancer Immunotherapy Breast Cancer Market by Country
6.4.2.3   LAMEA Cancer Immunotherapy Colorectal Cancer Market by Country
6.4.2.4   LAMEA Cancer Immunotherapy Melanoma Market by Country
6.4.2.5   LAMEA Cancer Immunotherapy Prostate Cancer Market by Country
6.4.2.6   LAMEA Cancer Immunotherapy Head & Neck Cancer Market by Country
6.4.2.7   LAMEA Other Application Cancer Immunotherapy Market by Country
6.4.3   LAMEA Cancer Immunotherapy Market by End User
6.4.3.1   LAMEA Hospitals Cancer Immunotherapy Market by Country
6.4.3.2   LAMEA Clinics Cancer Immunotherapy Market by Country
6.4.3.3   LAMEA Other End User Cancer Immunotherapy Market by Country
6.4.4   LAMEA Cancer Immunotherapy Market by Country
6.4.4.1   Brazil Cancer Immunotherapy Market
6.4.4.1.1   Brazil Cancer Immunotherapy Market by Technology
6.4.4.1.2   Brazil Cancer Immunotherapy Market by Application
6.4.4.1.3   Brazil Cancer Immunotherapy Market by End User
6.4.4.2   Argentina Cancer Immunotherapy Market
6.4.4.2.1   Argentina Cancer Immunotherapy Market by Technology
6.4.4.2.2   Argentina Cancer Immunotherapy Market by Application
6.4.4.2.3   Argentina Cancer Immunotherapy Market by End User
6.4.4.3   UAE Cancer Immunotherapy Market
6.4.4.3.1   UAE Cancer Immunotherapy Market by Technology
6.4.4.3.2   UAE Cancer Immunotherapy Market by Application
6.4.4.3.3   UAE Cancer Immunotherapy Market by End User
6.4.4.4   Saudi Arabia Cancer Immunotherapy Market
6.4.4.4.1   Saudi Arabia Cancer Immunotherapy Market by Technology
6.4.4.4.2   Saudi Arabia Cancer Immunotherapy Market by Application
6.4.4.4.3   Saudi Arabia Cancer Immunotherapy Market by End User
6.4.4.5   South Africa Cancer Immunotherapy Market
6.4.4.5.1   South Africa Cancer Immunotherapy Market by Technology
6.4.4.5.2   South Africa Cancer Immunotherapy Market by Application
6.4.4.5.3   South Africa Cancer Immunotherapy Market by End User
6.4.4.6   Nigeria Cancer Immunotherapy Market
6.4.4.6.1   Nigeria Cancer Immunotherapy Market by Technology
6.4.4.6.2   Nigeria Cancer Immunotherapy Market by Application
6.4.4.6.3   Nigeria Cancer Immunotherapy Market by End User
6.4.4.7   Rest of LAMEA Cancer Immunotherapy Market
6.4.4.7.1   Rest of LAMEA Cancer Immunotherapy Market by Technology
6.4.4.7.2   Rest of LAMEA Cancer Immunotherapy Market by Application
6.4.4.7.3   Rest of LAMEA Cancer Immunotherapy Market by End User
Chapter 7.   Company Profiles
7.1   Amgen Inc.
7.1.1   Company Overview
7.1.2   Financial Analysis
7.1.3   Segmental & Regional Analysis
7.1.4   Research and Development Expense
7.2   Merck & Company, Inc.
7.2.1   Company Overview
7.2.2   Financial Analysis
7.2.3   Regional and Segmental Analysis
7.2.4   Research & Development
7.3   Pfizer Inc.
7.3.1   Company Overview
7.3.2   Financial Analysis
7.3.3   Segmental &Regional Analysis
7.3.4   Revenue analysis by Region
7.3.5   Research and Development
7.4   Immunomedics Inc.
7.4.1   Company Overview
7.4.2   Financial Analysis
7.4.3   Revenue Analysis by Region
7.4.4   Research and Development
7.5   Astrazeneca Plc.
7.5.1   Company Overview
7.5.2   Financial Analysis
7.5.3   Segmental analysis
7.5.4   Research & Development
7.6   F. Hoffmann-La Roche Ltd.
7.6.1   Company Overview
7.6.2   Financial Analysis
7.6.3   Revenue & Segment analysis
7.6.4   Research and Development
7.7   Eli Lilly and Company
7.7.1   Company Overview
7.7.2   Financial Analysis
7.7.3   Segmental and Regional Analysis
7.7.4   Research & Development Expense
7.8   Novartis AG
7.8.1   Company Overview
7.8.2   Financial Analysis
7.8.3   Segmental and Regional Analysis
7.8.4   Research & Development Expense
7.9   Bristol-Myers Squibb Company
7.9.1   Company Overview
7.1   Bayer AG
7.10.1   Company Overview
7.10.2   Financial Analysis
7.10.3   Segmental and Regional Analysis
7.10.4   Research & Development Expense

List of Tables

TABLE 1 GLOBAL CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 2 GLOBAL CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 3 GLOBAL CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 4 GLOBAL CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 5 GLOBAL MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 6 GLOBAL MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 7 GLOBAL CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 8 GLOBAL CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 9 GLOBAL OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 10 GLOBAL OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 11 GLOBAL CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 12 GLOBAL CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 13 GLOBAL CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 14 GLOBAL CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 15 GLOBAL CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 16 GLOBAL CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 17 GLOBAL CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 18 GLOBAL CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 19 GLOBAL CANCER IMMUNOTHERAPY MELANOMA MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 20 GLOBAL CANCER IMMUNOTHERAPY MELANOMA MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 21 GLOBAL CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 22 GLOBAL CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 23 GLOBAL CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 24 GLOBAL CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 25 GLOBAL OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 26 GLOBAL OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 27 GLOBAL CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 28 GLOBAL CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 29 GLOBAL HOSPITALS CANCER IMMUNOTHERAPY MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 30 GLOBAL HOSPITALS CANCER IMMUNOTHERAPY MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 31 GLOBAL CLINICS CANCER IMMUNOTHERAPY MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 32 GLOBAL CLINICS CANCER IMMUNOTHERAPY MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 33 GLOBAL OTHER END USER CANCER IMMUNOTHERAPY MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 34 GLOBAL OTHER END USER CANCER IMMUNOTHERAPY MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 35 GLOBAL CANCER IMMUNOTHERAPY MARKET BY REGION, 2014 - 2017, USD MILLION
TABLE 36 GLOBAL CANCER IMMUNOTHERAPY MARKET BY REGION, 2018 - 2024, USD MILLION
TABLE 37 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 38 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 39 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 40 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 41 NORTH AMERICA MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42 NORTH AMERICA MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43 NORTH AMERICA CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 44 NORTH AMERICA CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 45 NORTH AMERICA OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 46 NORTH AMERICA OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 47 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 48 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 49 NORTH AMERICA CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 50 NORTH AMERICA CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 51 NORTH AMERICA CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 52 NORTH AMERICA CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 53 NORTH AMERICA CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 54 NORTH AMERICA CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 55 NORTH AMERICA CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 56 NORTH AMERICA CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 57 NORTH AMERICA CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 58 NORTH AMERICA CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 59 NORTH AMERICA CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 60 NORTH AMERICA CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 61 NORTH AMERICA OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 62 NORTH AMERICA OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 63 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 64 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 65 NORTH AMERICA HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 66 NORTH AMERICA HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 67 NORTH AMERICA CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 68 NORTH AMERICA CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 69 NORTH AMERICA OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 70 NORTH AMERICA OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 71 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 72 NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 73 US CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 74 US CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 75 US CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 76 US CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 77 US CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 78 US CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 79 US CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 80 US CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 81 CANADA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 82 CANADA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 83 CANADA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 84 CANADA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 85 CANADA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 86 CANADA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 87 CANADA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 88 CANADA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 89 MEXICO CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 90 MEXICO CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 91 MEXICO CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 92 MEXICO CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 93 MEXICO CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 94 MEXICO CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 95 MEXICO CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 96 MEXICO CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 97 REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 98 REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 99 REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 100 REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 101 REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 102 REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 103 REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 104 REST OF NORTH AMERICA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 105 EUROPE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 106 EUROPE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 107 EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 108 EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 109 EUROPE MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 110 EUROPE MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 111 EUROPE CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 112 EUROPE CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 113 EUROPE OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 114 EUROPE OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 115 EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 116 EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 117 EUROPE CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 118 EUROPE CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 119 EUROPE CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 120 EUROPE CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 121 EUROPE CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 122 EUROPE CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 123 EUROPE CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 124 EUROPE CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 125 EUROPE CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 126 EUROPE CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 127 EUROPE CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 128 EUROPE CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 129 EUROPE OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 130 EUROPE OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 131 EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 132 EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 133 EUROPE HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 134 EUROPE HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 135 EUROPE CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 136 EUROPE CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 137 EUROPE OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 138 EUROPE OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 139 EUROPE CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 140 EUROPE CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 141 GERMANY CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 142 GERMANY CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 143 GERMANY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 144 GERMANY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 145 GERMANY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 146 GERMANY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 147 GERMANY CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 148 GERMANY CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 149 UK CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 150 UK CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 151 UK CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 152 UK CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 153 UK CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 154 UK CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 155 UK CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 156 UK CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 157 FRANCE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 158 FRANCE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 159 FRANCE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 160 FRANCE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 161 FRANCE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 162 FRANCE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 163 FRANCE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 164 FRANCE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 165 RUSSIA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 166 RUSSIA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 167 RUSSIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 168 RUSSIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 169 RUSSIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 170 RUSSIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 171 RUSSIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 172 RUSSIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 173 SPAIN CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 174 SPAIN CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 175 SPAIN CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 176 SPAIN CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 177 SPAIN CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 178 SPAIN CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 179 SPAIN CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 180 SPAIN CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 181 ITALY CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 182 ITALY CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 183 ITALY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 184 ITALY CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 185 ITALY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 186 ITALY CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 187 ITALY CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 188 ITALY CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 189 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 190 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 191 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 192 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 193 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 194 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 195 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 196 REST OF EUROPE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 197 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 198 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 199 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 200 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 201 ASIA PACIFIC MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 202 ASIA PACIFIC MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 203 ASIA PACIFIC CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 204 ASIA PACIFIC CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 205 ASIA PACIFIC OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 206 ASIA PACIFIC OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 207 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 208 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 209 ASIA PACIFIC CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 210 ASIA PACIFIC CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 211 ASIA PACIFIC CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 212 ASIA PACIFIC CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 213 ASIA PACIFIC CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 214 ASIA PACIFIC CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 215 ASIA PACIFIC CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 216 ASIA PACIFIC CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 217 ASIA PACIFIC CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 218 ASIA PACIFIC CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 219 ASIA PACIFIC CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 220 ASIA PACIFIC CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 221 ASIA PACIFIC OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 222 ASIA PACIFIC OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 223 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 224 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 225 ASIA PACIFIC HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 226 ASIA PACIFIC HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 227 ASIA PACIFIC CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 228 ASIA PACIFIC CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 229 ASIA PACIFIC OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 230 ASIA PACIFIC OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 231 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 232 ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 233 CHINA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 234 CHINA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 235 CHINA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 236 CHINA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 237 CHINA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 238 CHINA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 239 CHINA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 240 CHINA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 241 JAPAN CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 242 JAPAN CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 243 JAPAN CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 244 JAPAN CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 245 JAPAN CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 246 JAPAN CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 247 JAPAN CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 248 JAPAN CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 249 INDIA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 250 INDIA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 251 INDIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 252 INDIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 253 INDIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 254 INDIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 255 INDIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 256 INDIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 257 SOUTH KOREA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 258 SOUTH KOREA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 259 SOUTH KOREA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 260 SOUTH KOREA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 261 SOUTH KOREA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 262 SOUTH KOREA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 263 SOUTH KOREA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 264 SOUTH KOREA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 265 SINGAPORE CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 266 SINGAPORE CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 267 SINGAPORE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 268 SINGAPORE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 269 SINGAPORE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 270 SINGAPORE CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 271 SINGAPORE CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 272 SINGAPORE CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 273 MALAYSIA CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 274 MALAYSIA CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 275 MALAYSIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 276 MALAYSIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 277 MALAYSIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 278 MALAYSIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 279 MALAYSIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2014 - 2017, USD MILLION
TABLE 280 MALAYSIA CANCER IMMUNOTHERAPY MARKET BY END USER, 2018 - 2024, USD MILLION
TABLE 281 REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET, 2014 - 2017, USD MILLION
TABLE 282 REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET, 2018 - 2024, USD MILLION
TABLE 283 REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2014 - 2017, USD MILLION
TABLE 284 REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY, 2018 - 2024, USD MILLION
TABLE 285 REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 286 REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 287 REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY END USER 2014 - 2017 USD MILLION
TABLE 288 REST OF ASIA PACIFIC CANCER IMMUNOTHERAPY MARKET BY END USER 2018 - 2024 USD MILLION
TABLE 289 LAMEA CANCER IMMUNOTHERAPY MARKET 2014 - 2017 USD MILLION
TABLE 290 LAMEA CANCER IMMUNOTHERAPY MARKET 2018 - 2024 USD MILLION
TABLE 291 LAMEA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2014 - 2017 USD MILLION
TABLE 292 LAMEA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2018 - 2024 USD MILLION
TABLE 293 LAMEA MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 294 LAMEA MONOCLONAL ANTIBODIES CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 295 LAMEA CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 296 LAMEA CYTOKINES & IMMUNOMODULATORS CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 297 LAMEA OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 298 LAMEA OTHER TECHNOLOGY CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 299 LAMEA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2014 - 2017 USD MILLION
TABLE 300 LAMEA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2018 - 2024 USD MILLION
TABLE 301 LAMEA CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 302 LAMEA CANCER IMMUNOTHERAPY LUNG CANCER MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 303 LAMEA CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 304 LAMEA CANCER IMMUNOTHERAPY BREAST CANCER MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 305 LAMEA CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 306 LAMEA CANCER IMMUNOTHERAPY COLORECTAL CANCER MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 307 LAMEA CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 308 LAMEA CANCER IMMUNOTHERAPY MELANOMA MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 309 LAMEA CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 310 LAMEA CANCER IMMUNOTHERAPY PROSTATE CANCER MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 311 LAMEA CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 312 LAMEA CANCER IMMUNOTHERAPY HEAD & NECK CANCER MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 313 LAMEA OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 314 LAMEA OTHER APPLICATION CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 315 LAMEA CANCER IMMUNOTHERAPY MARKET BY END USER 2014 - 2017 USD MILLION
TABLE 316 LAMEA CANCER IMMUNOTHERAPY MARKET BY END USER 2018 - 2024 USD MILLION
TABLE 317 LAMEA HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 318 LAMEA HOSPITALS CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 319 LAMEA CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 320 LAMEA CLINICS CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 321 LAMEA OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 322 LAMEA OTHER END USER CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 323 LAMEA CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2014 - 2017 USD MILLION
TABLE 324 LAMEA CANCER IMMUNOTHERAPY MARKET BY COUNTRY 2018 - 2024 USD MILLION
TABLE 325 BRAZIL CANCER IMMUNOTHERAPY MARKET 2014 - 2017 USD MILLION
TABLE 326 BRAZIL CANCER IMMUNOTHERAPY MARKET 2018 - 2024 USD MILLION
TABLE 327 BRAZIL CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2014 - 2017 USD MILLION
TABLE 328 BRAZIL CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2018 - 2024 USD MILLION
TABLE 329 BRAZIL CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2014 - 2017 USD MILLION
TABLE 330 BRAZIL CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2018 - 2024 USD MILLION
TABLE 331 BRAZIL CANCER IMMUNOTHERAPY MARKET BY END USER 2014 - 2017 USD MILLION
TABLE 332 BRAZIL CANCER IMMUNOTHERAPY MARKET BY END USER 2018 - 2024 USD MILLION
TABLE 333 ARGENTINA CANCER IMMUNOTHERAPY MARKET 2014 - 2017 USD MILLION
TABLE 334 ARGENTINA CANCER IMMUNOTHERAPY MARKET 2018 - 2024 USD MILLION
TABLE 335 ARGENTINA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2014 - 2017 USD MILLION
TABLE 336 ARGENTINA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2018 - 2024 USD MILLION
TABLE 337 ARGENTINA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2014 - 2017 USD MILLION
TABLE 338 ARGENTINA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2018 - 2024 USD MILLION
TABLE 339 ARGENTINA CANCER IMMUNOTHERAPY MARKET BY END USER 2014 - 2017 USD MILLION
TABLE 340 ARGENTINA CANCER IMMUNOTHERAPY MARKET BY END USER 2018 - 2024 USD MILLION
TABLE 341 UAE CANCER IMMUNOTHERAPY MARKET 2014 - 2017 USD MILLION
TABLE 342 UAE CANCER IMMUNOTHERAPY MARKET 2018 - 2024 USD MILLION
TABLE 343 UAE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2014 - 2017 USD MILLION
TABLE 344 UAE CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2018 - 2024 USD MILLION
TABLE 345 UAE CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2014 - 2017 USD MILLION
TABLE 346 UAE CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2018 - 2024 USD MILLION
TABLE 347 UAE CANCER IMMUNOTHERAPY MARKET BY END USER 2014 - 2017 USD MILLION
TABLE 348 UAE CANCER IMMUNOTHERAPY MARKET BY END USER 2018 - 2024 USD MILLION
TABLE 349 SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET 2014 - 2017 USD MILLION
TABLE 350 SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET 2018 - 2024 USD MILLION
TABLE 351 SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2014 - 2017 USD MILLION
TABLE 352 SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2018 - 2024 USD MILLION
TABLE 353 SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2014 - 2017 USD MILLION
TABLE 354 SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2018 - 2024 USD MILLION
TABLE 355 SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET BY END USER 2014 - 2017 USD MILLION
TABLE 356 SAUDI ARABIA CANCER IMMUNOTHERAPY MARKET BY END USER 2018 - 2024 USD MILLION
TABLE 357 SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET 2014 - 2017 USD MILLION
TABLE 358 SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET 2018 - 2024 USD MILLION
TABLE 359 SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2014 - 2017 USD MILLION
TABLE 360 SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2018 - 2024 USD MILLION
TABLE 361 SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2014 - 2017 USD MILLION
TABLE 362 SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2018 - 2024 USD MILLION
TABLE 363 SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET BY END USER 2014 - 2017 USD MILLION
TABLE 364 SOUTH AFRICA CANCER IMMUNOTHERAPY MARKET BY END USER 2018 - 2024 USD MILLION
TABLE 365 NIGERIA CANCER IMMUNOTHERAPY MARKET 2014 - 2017 USD MILLION
TABLE 366 NIGERIA CANCER IMMUNOTHERAPY MARKET 2018 - 2024 USD MILLION
TABLE 367 NIGERIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2014 - 2017 USD MILLION
TABLE 368 NIGERIA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2018 - 2024 USD MILLION
TABLE 369 NIGERIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2014 - 2017 USD MILLION
TABLE 370 NIGERIA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2018 - 2024 USD MILLION
TABLE 371 NIGERIA CANCER IMMUNOTHERAPY MARKET BY END USER 2014 - 2017 USD MILLION
TABLE 372 NIGERIA CANCER IMMUNOTHERAPY MARKET BY END USER 2018 - 2024 USD MILLION
TABLE 373 REST OF LAMEA CANCER IMMUNOTHERAPY MARKET 2014 - 2017 USD MILLION
TABLE 374 REST OF LAMEA CANCER IMMUNOTHERAPY MARKET 2018 - 2024 USD MILLION
TABLE 375 REST OF LAMEA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2014 - 2017 USD MILLION
TABLE 376 REST OF LAMEA CANCER IMMUNOTHERAPY MARKET BY TECHNOLOGY 2018 - 2024 USD MILLION
TABLE 377 REST OF LAMEA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2014 - 2017 USD MILLION
TABLE 378 REST OF LAMEA CANCER IMMUNOTHERAPY MARKET BY APPLICATION 2018 - 2024 USD MILLION
TABLE 379 REST OF LAMEA CANCER IMMUNOTHERAPY MARKET BY END USER 2014 - 2017 USD MILLION
TABLE 380 REST OF LAMEA CANCER IMMUNOTHERAPY MARKET BY END USER 2018 - 2024 USD MILLION
TABLE 381 KEY INFORMATION-AMGEN INC.
TABLE 382 KEY INFORMATION-MERCK & COMPANY INC.
TABLE 383 KEY INFORMATION- PFIZER INC.
TABLE 384 KEY INFORMATION- IMMUNOMEDICS INC.
TABLE 385 KEY INFORMATION- ASTRAZENECA PLC.
TABLE 386 KEY INFORMATION- F. HOFFMANN-LA ROCHE LTD.
TABLE 387 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 388 KEY INFORMATION – NOVARTIS AG
TABLE 389 KEY INFORMATION - BRISTOL-MYERS SQUIBB COMPANY
TABLE 390 KEY INFORMATION – BAYER AG